View in EDS

Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective—A report by Polish Myeloma Study Group.

Saved in:
Bibliographic Details
Title: Case-adjusted bortezomib-based strategy in routine therapy of relapsed/refractory multiple myeloma shown to be highly effective—A report by Polish Myeloma Study Group.
Authors: Walter-Croneck, Adam1 pgsz@hematoonkologia.pl, Grzasko, Norbert1, Soroka-Wojtaszko, Maria1, Jurczyszyn, Artur2, Torosian, Tigran3, Rymko, Marcin4, Nowicki, Adam5, Druzd-Sitek, Agnieszka6, Lech-Maranda, Ewa7,8, Madro, Elzbieta8, Zielinska, Patrycja9, Grygoruk-Wisniowska, Iwona10, Blonska, Danuta10, Usnarska-Zubkiewicz, Lidia11, Potoczek, Stanislaw11, Iskierka, Elzbieta12, Masternak, Anna13, Holojda, Jadwiga14, Dawidowska, Dorota14, Gawron, Ludmila14
Source: Leukemia Research. Jul2014, Vol. 38 Issue 7, p788-794. 7p.
Database: Academic Search Ultimate
Description
ISSN:01452126
DOI:10.1016/j.leukres.2014.04.011